HQY· Health Care› Health Information Services

HealthEquity, Inc.

Stage 3 · Topping · week 3

As of Oct 22, 2026, HealthEquity is in Stage 3, the topping phase, now in week 3 (since Oct 2, 2026). It closed at $100.97, 5.4% below its 52-week high and above its 200-day average, which is falling.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. More about the company

$100.97

+3.16% today

$8.4B · Mid cap

Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is HQY early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 15w

S2 22w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 15w → S3 8w → S2 15w → S3 5w → S2 7w → S3 5w → S4 4w → S1 2w → S2 22w → S3 6w → S4 4w → S1 2w → S2 8w → S3 1w → S4 10w → S1 3w → S2 7w → S3 2w → S4 13w → S1 11w → S2 11w → S3 3w current

Total tracked: 165 weeks across 22 stage runs.

HQY among Health Information Services12th of 41 by relative strength

All 41 →

Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	AMWLAmerican Well Corporation Class A	Stage 2 · wk 25	97	+7.4%
2	HNGEHinge Health, Inc. Class A	Stage 2 · wk 20	96	+19.1%
3	BTSGBrightSpring Health Services, Inc.	Stage 3 · wk 8	94	+9.1%
4	NRCNRC Health	Stage 3 · wk 4	93	−0.1%
5	SOPHSOPHiA GENETICS SA	Stage 2 · wk 24	91	−12.7%
6	HTFLHeartflow, Inc.	Stage 2 · wk 10	87	+17.0%
7	HSTMHealthStream, Inc.	Stage 2 · wk 17	77	+20.3%
8	OMCLOmnicell, Inc.	Stage 4 · wk 10	70	+12.5%
…12	HQYHealthEquity, Inc.	Stage 3 · wk 3	59	+11.7%

vs 52W High

-5.4%

$73.21 lo$106.79 hi

5.4% below 52W high, weakening from peak

The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.

Stage Maturity

Week 3

1w13w26w

Week 3, early distribution

How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.

vs 200 DMA

13.9%

200 DMA: $88.67 · sloping down

Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.

Rel Volume

1.45x

vs 50-day avg

Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.

Trend Health

→

Short-term trend flat

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+11.7%

+6.7%

+29.9%

YTD

+10.9%

+5.2%

Scan Membership

Breakout Watch

Latest: 2025-06-18

11 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S3

Wk 3 · Vol 1.45x

2026-10-21S3

Wk 3 · Vol 0.83x

2026-10-20S3

Wk 3 · Vol 0.65x

2026-10-19S3

Wk 3 · Vol 0.62x

2026-10-16S3

Wk 3 · Vol 0.64x

2026-10-15S3

Wk 2 · Vol 0.85x

2026-10-14S3

Wk 2 · Vol 0.95x

2026-10-13S3

Wk 2 · Vol 1.00x

2026-10-12S3

Wk 2 · Vol 0.71x

2026-10-09S3

Wk 2 · Vol 0.65x

2026-10-08S3

Wk 1 · Vol 0.90x

2026-10-07S3

Wk 1 · Vol 1.04x

Moving averages & range

50 DMA

$95.57

200 DMA

$88.67

52W High

$106.79

52W Low

$73.21

5D Low

$92.03

Resistance levels (recent highs)

20d High

$100.97

60d High

$106.79

120d High

$106.79

250d High

$106.79

Next resistance

+5.8%

to 60d High

P/E (TTM)

36.5

Forward 18.4

Earnings Growth (YoY)

+14.7%

Revenue +7.6%

ROE

+11.4%

Profit margin +17.4%

Dividend Yield

0.00%

P/B 4.2

HealthEquity: quick answers

What stage is HealthEquity in?

As of Oct 22, 2026, HealthEquity (HQY) is in Stage 3, the topping phase. It entered Stage 3 on Oct 2, 2026 and is in week 3. What the four stages mean

Is HealthEquity in an uptrend?

Its uptrend has stalled. HealthEquity is in Stage 3, the topping phase that follows an advance. It trades 13.9% above its 200-day average, which is falling.

How far is HealthEquity from its 52-week high?

HealthEquity closed at $100.97 on Oct 22, 2026, 5.4% below its 52-week high of $106.79. Its 52-week low is $73.21.

How has HealthEquity performed over the past year?

As of Oct 22, 2026, HealthEquity is up 5.2% over the past year and up 10.9% so far in 2026.

Which sector and industry is HealthEquity in?

HealthEquity is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.